SEC Info - Nunzia Pharmaceutical Co. - ‘10-Q’ for 9/30/22

SEC Info℠

Home

Help

Please Sign In

Nunzia Pharmaceutical Co. – ‘10-Q’ for 9/30/22 – ‘EX-101.DEF’

On: Monday, 11/14/22, at 8:00am ET · For: 9/30/22 · Accession #: 1683168-22-7586 · File #: 1-39175

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/22  Nunzia Pharmaceutical Co.         10-Q        9/30/22   31:1.5M                                   GlobalOne Filings Inc/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    354K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     15K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     15K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
10: R1          Cover                                               HTML     59K 
11: R2          Consolidated Balance Sheets (Unaudited)             HTML     75K 
12: R3          Consolidated Balance Sheets (Unaudited)             HTML     23K 
                (Parenthetical)                                                  
13: R4          Consolidated Statements of Operations (Unaudited)   HTML     46K 
14: R5          Consolidated Statements of Operations (Unaudited)   HTML     30K 
                (Parenthetical)                                                  
15: R6          Consolidated Statements of Stockholders' Deficit    HTML     76K 
                (Unaudited)                                                      
16: R7          Consolidated Statements of Cash Flows (Unaudited)   HTML     57K 
17: R8          Basis of Presentation, Organization, Going          HTML     22K 
                Concern, and Recent Accounting Pronouncements                    
18: R9          Summary of Significant Accounting Policies          HTML     33K 
19: R10         Preferred and Common Stock                          HTML     24K 
20: R11         Commitments and Contingencies                       HTML     15K 
21: R12         Transactions with Related Persons                   HTML     18K 
22: R13         Summary of Significant Accounting Policies          HTML     59K 
                (Policies)                                                       
23: R14         Basis of Presentation, Organization, Going          HTML     17K 
                Concern, and Recent Accounting Pronouncements                    
                (Details Narrative)                                              
24: R15         Summary of Significant Accounting Policies          HTML     17K 
                (Details Narrative)                                              
25: R16         Preferred and Common Stock (Details Narrative)      HTML     42K 
26: R17         Transactions with Related Persons (Details          HTML     24K 
                Narrative)                                                       
29: XML         IDEA XML File -- Filing Summary                      XML     46K 
27: XML         XBRL Instance -- nunzia_i10q-093022_htm              XML    329K 
28: EXCEL       IDEA Workbook of Financial Reports                  XLSX     44K 
 6: EX-101.CAL  XBRL Calculations -- nunz-20220930_cal               XML     56K 
 7: EX-101.DEF  XBRL Definitions -- nunz-20220930_def                XML    120K 
 8: EX-101.LAB  XBRL Labels -- nunz-20220930_lab                     XML    309K 
 9: EX-101.PRE  XBRL Presentations -- nunz-20220930_pre              XML    237K 
 5: EX-101.SCH  XBRL Schema -- nunz-20220930                         XSD     48K 
30: JSON        XBRL Instance as JSON Data -- MetaLinks              134±   183K 
31: ZIP         XBRL Zipped Folder -- 0001683168-22-007586-xbrl      Zip     83K

‘EX-101.DEF’ — XBRL Definitions — nunz-20220930_def

This Exhibit is an XBRL XML File.

<?xml version="1.0" standalone="no" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://nunziapharma.com/role/Cover" xlink:href="nunz-20220930.xsd#Cover" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/BalanceSheets" xlink:href="nunz-20220930.xsd#BalanceSheets" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/BalanceSheetsParenthetical" xlink:href="nunz-20220930.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/StatementsOfOperations" xlink:href="nunz-20220930.xsd#StatementsOfOperations" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/StatementsOfOperationsParenthetical" xlink:href="nunz-20220930.xsd#StatementsOfOperationsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/StatementsOfStockholdersDeficit" xlink:href="nunz-20220930.xsd#StatementsOfStockholdersDeficit" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/StatementsOfCashFlows" xlink:href="nunz-20220930.xsd#StatementsOfCashFlows" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncements" xlink:href="nunz-20220930.xsd#BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncements" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nunz-20220930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/PreferredAndCommonStock" xlink:href="nunz-20220930.xsd#PreferredAndCommonStock" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/CommitmentsAndContingencies" xlink:href="nunz-20220930.xsd#CommitmentsAndContingencies" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/TransactionsWithRelatedPersons" xlink:href="nunz-20220930.xsd#TransactionsWithRelatedPersons" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nunz-20220930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="nunz-20220930.xsd#BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="nunz-20220930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="nunz-20220930.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nunziapharma.com/role/TransactionsWithRelatedPersonsDetailsNarrative" xlink:href="nunz-20220930.xsd#TransactionsWithRelatedPersonsDetailsNarrative" xlink:type="simple"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/Cover" xlink:title="00000001 - Document - Cover"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets (Unaudited)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCash_70" xlink:type="arc" order="2"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapInvestmentOwnedAtCost_70" xlink:type="arc" order="3"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_70" xlink:type="arc" order="7"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_RelatedPartyShareholderNotePayable" xlink:label="loc_NUNZRelatedPartyShareholderNotePayable_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_NUNZRelatedPartyShareholderNotePayable_70" xlink:type="arc" order="8"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_70" xlink:type="arc" order="9"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="10"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="14"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_CommonStockPayable" xlink:label="loc_NUNZCommonStockPayable_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_NUNZCommonStockPayable_70" xlink:type="arc" order="15"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="16"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="17"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="18"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="19"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Unaudited) (Parenthetical)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/StatementsOfStockholdersDeficit" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders' Deficit (Unaudited)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_ClassACommonStockMember" xlink:label="loc_NUNZClassACommonStockMember_0"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NUNZClassACommonStockMember_0" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_ClassBCommonStockMember" xlink:label="loc_NUNZClassBCommonStockMember_10"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NUNZClassBCommonStockMember_10" xlink:type="arc" order="11"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_CommonStockPayableMember" xlink:label="loc_NUNZCommonStockPayableMember_20"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NUNZCommonStockPayableMember_20" xlink:type="arc" order="21"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_MergerSharesIssuedValue" xlink:label="loc_NUNZMergerSharesIssuedValue_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZMergerSharesIssuedValue_70" xlink:type="arc" order="4"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_MergerSharesIssuedShares" xlink:label="loc_NUNZMergerSharesIssuedShares_70"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_ReturnOfMergerSharesIssuedInErrorValue" xlink:label="loc_NUNZReturnOfMergerSharesIssuedInErrorValue_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZReturnOfMergerSharesIssuedInErrorValue_70" xlink:type="arc" order="6"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_ReturnOfMergerSharesIssuedInErrorShares" xlink:label="loc_NUNZReturnOfMergerSharesIssuedInErrorShares_70"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_SharesIssuedUnderSalesAndMarketingAgreement" xlink:label="loc_NUNZSharesIssuedUnderSalesAndMarketingAgreement_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZSharesIssuedUnderSalesAndMarketingAgreement_70" xlink:type="arc" order="8"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_CommonStockIssuedForLicenseAgreementWithMichaelMitsunaga" xlink:label="loc_NUNZCommonStockIssuedForLicenseAgreementWithMichaelMitsunaga_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZCommonStockIssuedForLicenseAgreementWithMichaelMitsunaga_70" xlink:type="arc" order="9"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_CommonStockIssuedForLicenseAgreementWithMichaelMitsunagaShares" xlink:label="loc_NUNZCommonStockIssuedForLicenseAgreementWithMichaelMitsunagaShares_70"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_SharesIssuedUnderMutualSalesAndMarketingAgreement" xlink:label="loc_NUNZSharesIssuedUnderMutualSalesAndMarketingAgreement_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZSharesIssuedUnderMutualSalesAndMarketingAgreement_70" xlink:type="arc" order="11"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_SharesIssuedUnderMutualSalesAndMarketingAgreementShares" xlink:label="loc_NUNZSharesIssuedUnderMutualSalesAndMarketingAgreementShares_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NUNZSharesIssuedUnderMutualSalesAndMarketingAgreementShares_70" xlink:type="arc" order="12"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncements" xlink:title="00000008 - Disclosure - Basis of Presentation, Organization, Going Concern, and Recent Accounting Pronouncements"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/PreferredAndCommonStock" xlink:title="00000010 - Disclosure - Preferred and Common Stock"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/CommitmentsAndContingencies" xlink:title="00000011 - Disclosure - Commitments and Contingencies"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/TransactionsWithRelatedPersons" xlink:title="00000012 - Disclosure - Transactions with Related Persons"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000013 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="00000014 - Disclosure - Basis of Presentation, Organization, Going Concern, and Recent Accounting Pronouncements (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000016 - Disclosure - Preferred and Common Stock (Details Narrative)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="0"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="3"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="4"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="5"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="6"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="7"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_70"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_70" xlink:type="arc" order="8"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" xlink:type="arc" order="9"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" xlink:type="arc" order="10"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://nunziapharma.com/role/TransactionsWithRelatedPersonsDetailsNarrative" xlink:title="00000017 - Disclosure - Transactions with Related Persons (Details Narrative)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30"/>

<link:loc xlink:type="locator" xlink:href="nunz-20220930.xsd#NUNZ_MichaelMitsunagaMember" xlink:label="loc_NUNZMichaelMitsunagaMember_0"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NUNZMichaelMitsunagaMember_0" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_40"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_40" xlink:type="arc" order="0"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_40"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_40" xlink:type="arc" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_40"/>

<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_40" xlink:type="arc" order="2"/>

</link:definitionLink>

</link:linkbase>

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/21  Nunzia Pharmaceutical Co.         8-K©:1      8/03/21    1:27K                                    1562884
 5/07/21  Nunzia Pharmaceutical Co.         8-K©:1      4/12/21    1:337K                                   1562884

↑Top

Filing Submission 0001683168-22-007586 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Nunzia Pharmaceutical Co. – ‘10-Q’ for 9/30/22 – ‘EX-101.DEF’

On: Monday, 11/14/22, at 8:00am ET · For: 9/30/22 · Accession #: 1683168-22-7586 · File #: 1-39175

Previous ‘10-Q’: ‘10-Q’ on 10/3/22 for 6/30/22 · Latest ‘10-Q’: This Filing · 2 References: To: Nunzia Pharmaceutical Co. – ‘8-K’ on 8/4/21 for 8/3/21 To: Nunzia Pharmaceutical Co. – ‘8-K’ on 5/7/21 for 4/12/21

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.DEF’ — XBRL Definitions — nunz-20220930_def

This Exhibit is an XBRL XML File.

2 Previous Filings that this Filing References

Previous ‘10-Q’: ‘10-Q’ on 10/3/22 for 6/30/22 · Latest ‘10-Q’: This Filing · 2 References:

Quarterly Report — Form 10-Q

Filing Table of Contents